SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

TherapeuticsMD Q3 EPS $(0.13) Up From $(0.16) YoY, Sales $23.72M Up From $3.473M YoY

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share. This is a 18.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported $23.72 million in sales

Benzinga · -

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share. This is a 18.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported $23.72 million in sales this quarter. This is a 582.98 percent increase over sales of $3.473 million the same period last year.